Back

New insights into glucagon-like peptide-1 receptor agonist treatment considerations.

26 August 2018 (13:10 - 13:25)
Organised by:
Congress Presentation Part of: Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice Diabetes and the Heart Open Access ESC Congress 2018

About the speaker

Photo
Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

3 More presentations in this session

Presentation thumbnail
Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.
Doctor B. Scirica (Boston, US)
Slides Video
Presentation thumbnail
Clinical aspects: type 2 diabetes, cardiovascular disease and glucagon-like peptide-1 receptor agonists.
Professor M. Pfeffer (Boston, US)
Slides Video
Presentation thumbnail
Perspective on glucagon-like peptide-1 receptor agonists in type 2 diabetes and cardiovascular disease: Interactive discussion.
Doctor B. Scirica (Boston, US) Professor M. Pfeffer (Boston, US) Professor S. Verma (Toronto, CA)
Slides Video

Access the full session

Session thumbnail
Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

The Event

Event poster

ESC Congress 2018

26 August 2018 13:10 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources